期刊文献+

栀子苷对小鼠肾脏缺血再灌注损伤的保护作用 被引量:5

Protective Effects of Geniposide on Renal Ischemic Reperfusion Injury in Mice
下载PDF
导出
摘要 目的研究栀子苷对小鼠肾脏缺血再灌注损伤的保护作用及作用机制。方法健康雄性C57小鼠60只随机分为假手术组,肾脏缺血再灌注损伤组,栀子苷低、中、高(5、10、20mg·kg^(-1))剂量组和阳性对照组。用无创血管夹夹闭左侧肾蒂1h,构建肾脏缺血再灌注损伤模型。再灌注24h后,检测血清中肌酐(Cr)、尿素氮(BUN)、核因子-κB(NF-κB)表达水平;评估肾脏过氧化氢酶(CAT)、谷胱甘肽过氧化物酶(GPx)和超氧化物歧化酶(SOD)活性,丙二醛(MDA)含量和病理形态;并检测血清和肾脏肿瘤坏死因子(TNF)-α、白细胞介素-1β(IL^(-1)β)和白细胞介素-6(IL-6)的表达。结果与肾脏缺血再灌注损伤组相比,栀子苷组血清中Cr、BUN和NF-κB表达明显降低,肾脏CAT、GPx和SOD活性明显增高,而MDA含量明显减少,病理形态改变明显减轻;此外,肾脏和血清中TNF-α、IL^(-1)β和IL-6的表达明显减少。结论栀子苷对肾脏缺血再灌注损伤有保护作用,其作用机制与减轻炎症反应和抑制氧化应激相关。 Objective To investigate the protective effect of geniposide(GEN)on renal ischemic reperfusion injury(IRI)and its molecular mechanism in mice.Methods Healthy male C57 mice were randomly divided into sham group,renal IRI group,GEN groups at the dosage of(5,10,20)mg·kg^-1 and positive control group.The model of IRI was induced by clamping the left renal pedicle for 1 hwith excision of the right kidney.After 24 hreperfusion,the serum levels of Cr,BUN and NF-κB were determined.The levels of MDA,renal pathology and activities of CAT,GPx and SOD in renal tissues were mesured.Furthermore,the expressions of TNF-α,IL-6 and IL-1βin serum and renal tissue were evaluated.Results Compared with IRI group,the GEN groups had lower levels of Cr,BUN,NF-κB,MDA,TNF-α,IL-6 and IL-1β,but higher activities of CAT,GPx and SOD.Moreover,the morphological changes of renal tissues in the GEN groups were attenuated.Conclusion GEN can protect the kidney against IRI,the mechanism of which is associated with reduced inflammation and suppressed oxidative stress.
出处 《解放军药学学报》 CAS CSCD 2017年第6期550-553,共4页 Pharmaceutical Journal of Chinese People's Liberation Army
基金 宜昌市科技基金 No.A1302-31
关键词 栀子苷 肾脏 缺血再灌注损伤 炎症 氧化应激 小鼠 geniposide renal ischemia reperfusion injury inflammtion oxidative stress mice
  • 相关文献

参考文献2

二级参考文献27

  • 1龚华渠,杨天德,陶军.高渗盐液预处理对大鼠缺血再灌注肾组织细胞间黏附分子-1表达的影响[J].重庆医学,2006,35(7):584-586. 被引量:1
  • 2师梅,李荣山.肾缺血预处理对膜脂质过氧化损伤的保护作用[J].中华器官移植杂志,2007,28(3):178-180. 被引量:3
  • 3Iniquez M,Dotor J,Feijoo E,et al.Novel pharmacologic strategies to protect the liver from ischemia-reperfusion injury[J].Rec Pat Card Drug Discov,2008,3(1):9-18.
  • 4Christophe M,Nicolas S.Mitochondria:a target for neuroprotective interventions in cerebral ischemia-reperfusion[J].Curr Pharm Des,2006,12(6):739-757.
  • 5Baatscheer A,Schumacher CA,et al.Increased Na+/H+-exchange activity is the cause of[Na+]I and underlies disturbed calcium handling in the rabbit pressure and volume overload heart failure model[J].Cardiovascular Research,2003,57(4):1015-1024.
  • 6Fomin VV.Ischemic renal disease:clinico-pathogenetic features,diagnostics,treatment[J].Klin Med,2008,86(4):8-14.
  • 7Toronyi E.Role of apoptosis in the kidney after reperfusion[J].Orv Hetil,2008,149(7):305-315.
  • 8Leslie JA,Meldrum KK.The role of interleukin-18 in renal injury[J].J Surg Res,2008,145(1):170-175.
  • 9Kher A,Meldrum KK,Wang M,et al.Cellular and molecular mechanisms of sex differences in renal ischemia-reperfusion injury[J].Cardiovasc Res,2005,67(4):594-603.
  • 10Huang Y,Rabb H,Womer KL.Ischemia-reperfusion and immediate T cell responses[J].Cell Immunol,2007,248(1):4-11.

共引文献20

同被引文献78

引证文献5

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部